Neoplasms, Myelogenous Leukemia, Acute
1 clinical trials · Condition
◉ Watch Neoplasms, Myelogenous Leukemia, Acute
| Record | Firm | Date |
|---|---|---|
| A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia. (NCT02098967) | Hoffmann-La Roche | 2014-04-21 |
Track Neoplasms, Myelogenous Leukemia, Acute automatically
Every clearance here is in the API, with alerts when new ones post.